These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9000533)

  • 1. Elevated levels of NO in both unchallenged and LPS-challenged C. parvum-primed mice are attributable to the activity of a cytokine-inducible isoform of iNOS.
    Smith SR; Manfra D; Davies L; Terminelli C; Denhardt G; Donkin J
    J Leukoc Biol; 1997 Jan; 61(1):24-32. PubMed ID: 9000533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS- and TNF-alpha-induced lethality.
    Smith SR; Terminelli C; Denhardt G; Narula S; Thorbecke GJ
    Cell Immunol; 1996 Nov; 173(2):207-14. PubMed ID: 8912878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cooperative effects of TNF-alpha and IFN-gamma are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia.
    Smith SR; Terminelli C; Kenworthy-Bott L; Calzetta A; Donkin J
    J Leukoc Biol; 1994 Jun; 55(6):711-8. PubMed ID: 8195696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum.
    Smith SR; Calzetta A; Bankowski J; Kenworthy-Bott L; Terminelli C
    J Leukoc Biol; 1993 Jul; 54(1):23-9. PubMed ID: 8336076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of lipopolysaccharide-induced NO synthase expression in the major organs in a mouse model. The roles of endogenous interferon-gamma, tumor necrosis factor-alpha and interleukin-10.
    ter Steege JC; van de Ven WC; Forget PP; Buurman WA
    Eur Cytokine Netw; 2000 Mar; 11(1):39-46. PubMed ID: 10705297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide (LPS) stimulates the production of tumor necrosis factor (TNF)-alpha and expression of inducible nitric oxide synthase (iNOS) by osteoclasts (OCL) in murine bone marrow cell culture.
    Kikkawa I; Saito S; Tominaga K; Hoshino Y; Ooi Y; Nakano M
    Microbiol Immunol; 1998; 42(9):591-8. PubMed ID: 9802559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage inflammatory protein-1 alpha production in lipopolysaccharide-stimulated human adherent blood mononuclear cells is inhibited by the nitric oxide synthase inhibitor N(G)-monomethyl-L-arginine.
    Mühl H; Dinarello CA
    J Immunol; 1997 Nov; 159(10):5063-9. PubMed ID: 9366434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage.
    Billiar TR; Curran RD; Harbrecht BG; Stuehr DJ; Demetris AJ; Simmons RL
    J Leukoc Biol; 1990 Dec; 48(6):565-9. PubMed ID: 2230601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats.
    Unno N; Wang H; Menconi MJ; Tytgat SH; Larkin V; Smith M; Morin MJ; Chavez A; Hodin RA; Fink MP
    Gastroenterology; 1997 Oct; 113(4):1246-57. PubMed ID: 9322519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation.
    Salvemini D; Wang ZQ; Wyatt PS; Bourdon DM; Marino MH; Manning PT; Currie MG
    Br J Pharmacol; 1996 Jun; 118(4):829-38. PubMed ID: 8799551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha regulates in vivo nitric oxide synthesis and induces liver injury during endotoxemia.
    Harbrecht BG; Di Silvio M; Demetris AJ; Simmons RL; Billiar TR
    Hepatology; 1994 Oct; 20(4 Pt 1):1055-60. PubMed ID: 7927208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between inducible isoforms of nitric oxide synthase and cyclo-oxygenase in vivo: investigations using the selective inhibitors, 1400W and celecoxib.
    Hamilton LC; Warner TD
    Br J Pharmacol; 1998 Sep; 125(2):335-40. PubMed ID: 9786506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant tissue factor pathway inhibitor prevents lipopolysaccharide-induced systemic hypotension in rats by inhibiting excessive production of nitric oxide.
    Enkhbaatar P; Okajima K; Uchiba M; Isobe H; Okabe H
    Thromb Haemost; 2001 Dec; 86(6):1573-7. PubMed ID: 11776329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the mouse inducible-type nitric oxide synthase gene promoter by interferon-gamma, bacterial lipopolysaccharide and NG-monomethyl-L-arginine.
    Weisz A; Cicatiello L; Esumi H
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):209-15. PubMed ID: 8645207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral nitric oxide in carrageenan-induced inflammation.
    Omote K; Hazama K; Kawamata T; Kawamata M; Nakayaka Y; Toriyabe M; Namiki A
    Brain Res; 2001 Sep; 912(2):171-5. PubMed ID: 11532433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
    Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
    J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
    Kim CK; Rivier C
    J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase.
    Warner RL; Paine R; Christensen PJ; Marletta MA; Richards MK; Wilcoxen SE; Ward PA
    Am J Respir Cell Mol Biol; 1995 Jun; 12(6):649-61. PubMed ID: 7539274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors.
    Tracey WR; Tse J; Carter G
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1011-5. PubMed ID: 7534350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12.
    Shnyra A; Brewington R; Alipio A; Amura C; Morrison DC
    J Immunol; 1998 Apr; 160(8):3729-36. PubMed ID: 9558074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.